Add SGIOF to Watchlist?
Some Reasons Why To Add SGIOF:
  • High gross margin of 82.4%
  • Strong operating margin of 32.1%
  • Healthy interest coverage ratio of 18.6x

SGIOF Performance

SGIOF Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Mar 30, 2027 Mar 30, 2027 Mar 30, 2027 $0.192 1.09%
2 Sep 29, 2026 Sep 29, 2026 Sep 29, 2026 $0.189 1.18%
3 May 12, 2025 Mar 31, 2026 Mar 31, 2026 $0.223 1.47%
4 May 12, 2025 Sep 30, 2025 Sep 30, 2025 $0.223 1.47%
5 Sep 29, 2025 Sep 29, 2025 Sep 29, 2025 $0 0%

FAQ

What is the symbol for Shionogi & Co., Ltd. Stock and on which exchange is it traded?
The symbol for Shionogi & Co., Ltd. is SGIOF and it is traded on the PINK (Pink Sheets).

Should I buy or sell Shionogi & Co., Ltd. Stock?
Shionogi & Co., Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Shionogi & Co., Ltd. Stock?
Shionogi & Co., Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Shionogi & Co., Ltd. Stock.

What's the current price of Shionogi & Co., Ltd. Stock?
As of the end of day on the Jun 22, 2026, the price of an Shionogi & Co., Ltd. (SGIOF) share was $18.80.

What is the 52-week high and low for Shionogi & Co., Ltd. Stock?
The 52-week high for Shionogi & Co., Ltd. Stock is $23.63 and the 52-week low is $14.25.

What is the market capitalization of Shionogi & Co., Ltd. Stock?
As of the Jun 22, 2026, the market capitalization of Shionogi & Co., Ltd. is 15.045B.

When is the next earnings date for Shionogi & Co., Ltd.?
The upcoming earnings date for Shionogi & Co., Ltd. is Aug 03, 2026.
Click to get the best stock tips daily for free!
ABOUT SHIONOGI & CO., LTD.
Shionogi & .
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Xofluza, an influenza virus drug; and Tivicay for HIV treatment. It also develops Symproic for opioid-induced constipation treatment; S-120083 for Inflammatory pain; S-010887 for Neuropathic pain; S-1...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE